(Q46860938)

25 December 2017

title

C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma (English)

1 reference

25 December 2017

4

Beyhan Cengiz

1 reference

25 December 2017

Hitoshi Nagatsuka

2

object named as

Hitoshi Nagatsuka

1 reference

25 December 2017

Hidetsugu Tsujigiwa

7

object named as

Hidetsugu Tsujigiwa

1 reference

25 December 2017

author name string

Rosario S Rivera

1

1 reference

25 December 2017

Mehmet Gunduz

3

1 reference

25 December 2017

Esra Gunduz

5

1 reference

25 December 2017

Chong Huat Siar

6

1 reference

25 December 2017

Ryo Tamamura

8

1 reference

25 December 2017

Kok Ng Han

9

1 reference

25 December 2017

Noriyuki Nagai

10

1 reference

25 December 2017

publication date

8 December 2007

1 reference

25 December 2017

published in

Virchows Archiv

1 reference

25 December 2017

volume

452

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

27-32

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00428-007-0524-2

exact match

0 references

cites work

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

1 reference

https://api.crossref.org/works/10.1007%2FS00428-007-0524-2

Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-007-0524-2

STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-007-0524-2

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-007-0524-2

Lack of clinical efficacy of imatinib in metastatic melanoma

21 January 2018

1 reference

12 December 2020

Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial

1 reference

12 December 2020

Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array

1 reference

12 December 2020

Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.

1 reference

12 December 2020

An immunohistochemical evaluation of c-kit (CD-117) expression in malignant melanoma, and results of imatinib mesylate (Gleevec) therapy in three patients

1 reference

12 December 2020

Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients

1 reference

12 December 2020

Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis

1 reference

12 December 2020

c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi.

1 reference

12 December 2020

The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression

1 reference

12 December 2020

Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression

1 reference

12 December 2020

Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes

1 reference

12 December 2020

Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor.

1 reference

12 December 2020

Somatic activation of KIT in distinct subtypes of melanoma

1 reference

12 December 2020

Imatinib in melanoma: a selective treatment option based on KIT mutation status?

1 reference

12 December 2020

c-Kit-dependent growth of uveal melanoma cells: a potential therapeutic target?

1 reference

12 December 2020

Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays

1 reference

12 December 2020

Clinical implications of C-kit gene mutation in patients with large gastrointestinal stromal tumors.

1 reference

12 December 2020

c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors

1 reference

12 December 2020

Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors

1 reference

12 December 2020

Primary Malignant Melanoma of the Oral Mucosa

1 reference

12 December 2020

Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec)

1 reference

12 December 2020

Oral mucosal melanomas: the WESTOP Banff workshop proceedings. Western Society of Teachers of Oral Pathology.

1 reference

12 December 2020

Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy

1 reference

12 December 2020

Oral mucosal melanoma: epidemiology and pathobiology

1 reference

12 December 2020

Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors

1 reference

12 December 2020

Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction

1 reference

12 December 2020

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

1 reference

12 December 2020

Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis

1 reference

12 December 2020

Chemotherapy and targeted therapy combinations in advanced melanoma

1 reference

12 December 2020

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.

1 reference

12 December 2020

Regulation of gene expression in melanoma: new approaches for treatment

1 reference

12 December 2020

Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.

1 reference

12 December 2020

Immunolocalization and distribution patterns of type IV collagen alpha chains in oral mucosal melanoma

1 reference

12 December 2020

Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells

1 reference

12 December 2020

Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions

1 reference

12 December 2020

Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis

1 reference

12 December 2020

10.1007/S00428-007-0524-2

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18066592

1 reference

25 December 2017